Duloxetine as an Analgesic Agent in Patients Undergoing Elective Spine Surgery
Status:
Completed
Trial end date:
2015-10-30
Target enrollment:
Participant gender:
Summary
Duloxetine as an analgesic agent in patients undergoing elective spine surgery: evaluation
with fentanyl demand controlled by the patient. The primary objective is to evaluate the
efficacy of duloxetine in fentanyl consumption during the postoperative period of patients
undergoing elective spine surgery by intervertebral disc degeneration . Secondary endpoints
were pain scores and the presence or absence of adverse effects such as headache, nausea,
vomiting, itching, dizziness and drowsiness.